Maximize Returns with AI-Powered APLS Insights




APLS Forecast


Bearish   <—>   Bullish



80% Confidence



Bullish Case: APLS could benefit from recent positive clinical results and potential new market entries, which may boost investor confidence and increase the stock price.



Bearish Case: APLS faces potential declines due to a high cash burn rate, previous stock underperformance, and substantial competition in the biotech marketplace.



Potential Outcomes:
  • 35% chance of price recovery driven by successful trials and new approvals.
  • 50% probability of further decline due to high volatility and competition.
  • 15% likelihood of stabilization around $30 as market evaluates data.



Trading Oracle: A bearish short volatility strategy is advisable. Sell APLS $31 calls and buy APLS $32 calls, benefiting from high implied volatility and a 68% probability of profit. Time outlook is 25 days, with a 25% potential return, capitalizing on prevailing market sentiments and vol dynamics.


January 28, 2025


Apellis Pharmaceuticals Forecast

APLS        Apellis Pharmaceuticals

4 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts















Become a more profitable investor with AI optimized trading strategies





×

Chat with APLS


 Ask any question about APLS!